Abstract:Abstract Preclinical and clinical proof-of-concept studies have suggested the effectiveness of pharmacological modulation of inflammatory cytokines in ischemic stroke. Experimental evidence shows that targeting tumor necrosis factor (TNF) and interleukin (IL)-1 holds promise, and these cytokines are considered prime targets in the development of new stroke therapies. So far, however, information on the cellular expression of TNF and IL-1 in the human ischemic brain is sparse. We studied 14 cases of human post-mortem ischemic stroke, representing 21 specimens of infarcts aged 1 to > 8 days. We characterized glial and leukocyte reactions in the infarct/peri-infarct (I/PI) and normal-appearing tissue (NAT) and the cellular location of TNF, TNF receptor (TNFR)1 and TNFR2, IL-1α, IL-1β, and IL-1 receptor antagonist (IL-1Ra). The immunohistochemically stained tissue sections received a score reflecting the number of immunoreactive cells and the intensity of the immunoreactivity (IR) in individual cells where 0 = no immunoreactive cells, 1 = many intermediately to strongly immunoreactive cells, and 2 = numerous and intensively immunoreactive cells. Additionally, we measured blood TNF, TNFR, and IL-1 levels in surviving ischemic stroke patients within the first 8 h and again at 72 h after symptom onset and compared levels to healthy controls. We observed IL-1α and IL-1β IR in neurons, glia, and macrophages in all specimens. IL-1Ra IR was found in glia, in addition to macrophages. TNF IR was initially found in neurons located in I/PI and NAT but increased in glia in older infarcts. TNF IR increased in macrophages in all specimens. TNFR1 IR was found in neurons and glia and macrophages, while TNFR2 was expressed only by glia in I/PI and NAT, and by macrophages in I/PI. Our results suggest that TNF and IL-1 are expressed by subsets of cells and that TNFR2 is expressed in areas with increased astrocytic reactivity. In ischemic stroke patients, we demonstrate that plasma TNFR1 and TNFR2 levels increased in the acute phase after symptom onset compared to healthy controls, whereas TNF, IL-1α, IL-1β, and IL-1Ra did not change. Our findings of increased brain cytokines and plasma TNFR1 and TNFR2 support the hypothesis that targeting post-stroke inflammation could be a promising add-on therapy in ischemic stroke patients.

Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice.

Alterations in expression of GFAPmRNA and correlated protein after cerebral ischemia/reperfusion in rats

Tumor necrosis factor alpha expression produces increased blood–brain barrier permeability following temporary focal cerebral ischemia in mice

Expression of Tumor Necrosis Factor-Alpha and Intercellular Adhesion Molecule-1 after Focal Cerebral Ischemia in Interleukin-1Beta Converting Enzyme Deficient Mice.

Inhibition Of Tnf Alpha Attenuates Infarct Volume And Icam-1 Expression In Ischemic Mouse Brain

Expression of nuclear factor kappaB and tumor necrosis factor alpha in the mouse brain after experimental thermal ablation injury

Stroke upregulates TNFalpha transport across the blood-brain barrier.

Dual Roles of Tumor Necrosis Factor-Α Receptor-1 in a Mouse Model of Hindlimb Ischemia

Tumor Necrosis Factor-Α Promotes the Expression of Excitatory Amino-Acid Transporter 2 in Astrocytes: Optimal Concentration and Incubation Time.

Astrocytes Constitute the Major TNF-α-producing Cell Population in the Infarct Cortex in Dmcao Rats Receiving Intravenous MSC Infusion

Detection of Tumor Necrosis Factor-α mRNA Induction in Ischemic Brain Tolerance by Means of Real-Time Polymerase Chain Reaction

Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.

Inflammatory Reaction after Focal Cerebral Ischemia in Mouse.

Permanent occlusion of the middle cerebral artery upregulates expression of cytokines and neuronal nitric oxide synthase in the spinal cord and urinary bladder in the adult rat

Protein and Mrna Expression of TGF Β_1 During Reperfusion after Focal Cerebral Ischemia

Characterization of the Involvement of Tumour Necrosis Factor (TNF)-α-Stimulated Gene 6 (TSG-6) in Ischemic Brain Injury Caused by Middle Cerebral Artery Occlusion in Mouse

Increased Peripheral CD137 Expression in a Mouse Model of Permanent Focal Cerebral Ischemia

Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke

Attenuation of Temporary Focal Cerebral Ischemic Injury in the Mouse Following Transfection with Interleukin-1 Receptor Antagonist

Cathepsin C aggravates neuroinflammation via promoting production of CCL2 and CXCL2 in glial cells and neurons in a cryogenic brain lesion

Expression of Immediate Early Gene and Growth Factor Mrnas in a Focal Cerebral Ischemia Model in the Rat.